bullish
China Healthcare Weekly (Oct.9)
238 Views13 Oct 2020 09:53
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China healthcare industry.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO RemeGen - Insights on Two Core Products RC18 & RC4823 Oct 2020
- China Healthcare Weekly (Oct.16)19 Oct 2020
- Pre-IPO JD Health (JDH.HK) - A Better Candidate of Online Healthcare Business In China?15 Oct 2020
- A Different Angle - Simcere Pharmaceutical VS Everest Medicines (01952.HK)11 Oct 2020
- Betta Pharmaceuticals (300558.SZ) - The Harvest Season Is Coming07 Oct 2020
- Autonomous Driving- The Tesla Delusion06 Apr 2018
x